Obesity, POMC, and POMC-processing Enzymes: Surprising Results From Animal Models
- PMID: 34333593
- PMCID: PMC8489426
- DOI: 10.1210/endocr/bqab155
Obesity, POMC, and POMC-processing Enzymes: Surprising Results From Animal Models
Abstract
Peptides derived from proopiomelanocortin (POMC) are well-established neuropeptides and peptide hormones that perform multiple functions, including regulation of body weight. In humans and some animals, these peptides include α- and β-melanocyte-stimulating hormone (MSH). In certain rodent species, no β-MSH is produced from POMC because of a change in the cleavage site. Enzymes that convert POMC into MSH include prohormone convertases (PCs), carboxypeptidases (CPs), and peptidyl-α-amidating monooxygenase (PAM). Humans and mice with inactivating mutations in either PC1/3 or carboxypeptidase E (CPE) are obese, which was assumed to result from defective processing of POMC into MSH. However, recent studies have shown that selective loss of either PC1/3 or CPE in POMC-expressing cells does not cause obesity. These findings suggest that defects in POMC processing cannot alone account for the obesity observed in global PC1/3 or CPE mutants. We propose that obesity in animals lacking PC1/3 or CPE activity depends, at least in part, on deficient processing of peptides in non-POMC-expressing cells either in the brain and/or the periphery. Genetic background may also contribute to the manifestation of obesity.
Keywords: PC1/3; PC2; POMC; carboxypeptidase E; obesity; proprotein convertase.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society.
Figures

References
-
- Fricker LD. Neuropeptides and Other Bioactive Peptides: From Discovery to Function. Morgan & Claypool Life Sciences; 2012.
-
- Hoshino A, Lindberg I.. Peptide Biosynthesis: Prohormone Convertases 1/3 and 2. Morgan & Claypool Life Sciences; 2012.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous